Highlights Kronos Bio, Inc.

Equities

KRON

US50107A1043

Real-time Estimate Cboe BZX Other stock markets 01:46:51 2024-06-11 pm EDT			5-day change	1st Jan Change
1.11 ^USD	+16.72%		+45.24%	-14.14%

May. 23	Kronos Bio, Inc. to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology Annual Meeting	CI
May. 21	Kronos Bio, Inc. Announces Executive Changes	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Kronos Bio, Inc. to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology Annual Meeting	May. 23	CI
Earnings Flash (KRON) KRONOS BIO Reports Q1 Revenue $2.52M	May. 09	MT
Kronos Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Earnings Flash (KRON) KRONOS BIO Reports Q4 Revenue $2.3M	Mar. 21	MT
Kronos Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 21	CI
Kronos Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Kronos Bio, Inc. Announces to Assess KB-0742 At Planned New Dose Schedule in Ongoing Phase 1/2 Study	Mar. 07	CI
Kronos Bio, Inc. Announces Pipeline Update and p300 KAT Inhibitor Development Candidate	Dec. 18	CI
Earnings Flash (KRON) KRONOS BIO Reports Q3 Revenue $917,000	Nov. 13	MT
Kronos Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Kronos Bio to Present Positive Preliminary Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 Kb-0742 Study At the Connective Tissue Oncology Society Annual Meeting	23-10-27	CI
Kronos Bio, Inc. Presents Positive Preliminary Data from Phase 1 Dose Escalation Portion of Phase 1/2 KB-0742 Study At AACR-NCI-EORTC	23-10-13	CI
Earnings Flash (KRON) KRONOS BIO Reports Q2 Revenue $1.9M	23-08-08	MT
Kronos Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
Earnings Flash (KRON) KRONOS BIO Reports Q1 Revenue $1.2M	23-05-10	MT
Kronos Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
KRONOS BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-15	AQ
Kronos Bio Enters Into Drug Discovery Project With Genentech; Shares Rise	23-01-09	MT
Kronos Bio, Inc. Enters Into Collaboration and License Agreement with Genentech, Inc	23-01-09	CI
Kronos Bio, Inc. Announces Discovery Collaboration with Genentech to Advance Novel Therapies Against Transcriptional Targets in Oncology	23-01-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Kronos Bio, Inc.

Equities

KRON

US50107A1043

Highlights

Filters